Harry J. Leonhardt has been appointed senior vice president, general counsel and chief compliance officer, Halozyme Therapeutics, Inc. He will be responsible for all legal, compliance and intellectual property matters and reports to Dr. Helen Torley, president and chief executive officer. Mr. Leonhardt has more than 30 years of corporate legal, intellectual property, compliance, business development and M&A experience, with an extensive background in the biotechnology sector. He most recent...